LEADER 06354nam 22009733u 450 001 9910139555703321 005 20230725051122.0 010 $a1-283-24049-1 010 $a9786613240491 010 $a1-4443-4257-6 010 $a1-4443-4254-1 035 $a(CKB)2550000000045840 035 $a(EBL)819297 035 $a(OCoLC)759159254 035 $a(SSID)ssj0000633398 035 $a(PQKBManifestationID)12245060 035 $a(PQKBTitleCode)TC0000633398 035 $a(PQKBWorkID)10619848 035 $a(PQKB)11067818 035 $a(MiAaPQ)EBC819297 035 $a(EXLCZ)992550000000045840 100 $a20131104d2011|||| u|| | 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aClinical Dilemmas in Inflammatory Bowel Disease$b[electronic resource] $eNew Challenges 205 $a2nd ed. 210 $aHoboken $cWiley$d2011 215 $a1 online resource (286 p.) 300 $aDescription based upon print version of record. 311 $a1-4443-3454-9 327 $aClinical Dilemmas inInflammatoryBowel Disease; Contents; Contributors; Preface; Part I: Genes and Phenotype in IBD; 1 Which will take us further in IBD-study of coding variation or epigenetics?; 2 IBD in different ethnic groups: same or different?; Part II: Bugs and IBD-Good, Bad, or Indifferent?; 3 How does the risk of infection influence management of IBD around the world?; 4 Traveling with IBD; 5 What to do about hepatitis B and hepatitis C in patients with IBD; 6 CMV in IBD-passenger or pathogen?; 7 Clostridium difficile in IBD: impact, prevention, and treatment 327 $a8 Prebiotics and synbiotics: panacea or placebo9 Worms: light at the end of their burrow; 10 Do we really need to vaccinate all patients with IBD?; Part III: Investigating IBD; 11 Biomarkers in IBD: myth or marvel?; 12 Radiation exposure in IBD: how do we minimize the dangers?; 13 Surveillance colonoscopy in UC: what is the best way to do it?; Part IV: Medical Therapy; 5-ASA; 14 New 5-ASAs for ulcerative colitis: a tiny step or giant stride forward?; 15 Do 5-ASAs prevent cancer?; 16 Why do we still use 5-ASAs in Crohn's disease?; Steroids 327 $a17 Steroids in Crohn's disease: do the benefits outweigh the dangers?Immunomodulators; 18 Thioguanine nucleotide measurement: nonadherent, underdosed, shunter, or refractory?; 19 Thiopurines and the sun: what should be done?; 20 Do thiopurines worsen risk and prognosis of cervical neoplasia?; 21 Optimizing use of methotrexate; 22 Which calcineurin inhibitor and when?; Biologics; 23 Are all anti-TNF agents the same?; 24 One drug or two: do patients on biologics need concurrent immunomodulation?; 25 How do we identify patients needing early aggressive therapy and what should we use? 327 $a26 What is the role of biologics in UC?27 What can we do with Crohn's patients who fail or lose response to anti-TNF therapy?; 28 Which extraintestinal manifestations of IBD respond to biologics?; 29 Use and abuse of biologics in pregnancy; 30 Is anti-TNF therapy safe to use in people with a history of malignancy?; 31 The risks of immunomodulators and biologics: what should we tell patients?; 32 When, how, and in whom should we stop biologics?; Part V: Other Treatments; 33 Avoiding drug interactions 327 $a34 Is there still a role for ursodeoxycholic acid treatment patients with inflammatory bowel disease associated with primary sclerosing cholangitis?35 Stem cell transplantation for Crohn's: will it fulfill its promise?; 36 Complementary therapy: is there a needle in the haystack?; Part VI: Surgical Dilemmas in IBD; 37 Optimizing IBD patients for surgery and recovery; 38 Is surgery the best initial treatment for limited ileocecal Crohn's disease?; 39 Laparoscopic or open surgery for IBD?; 40 Optimizing management of perianal Crohn's disease 327 $a41 Does anti-TNF therapy increase the risk of complications of surgery? 330 $aThe second edition of Clinical Dilemmas in Inflammatory Bowel Disease: New Challenges, is a practical, up-to-date handbook providing expert guidance on specific clinical dilemmas and areas of difficulty that the gastroenterologist regularly faces in day-to-day practice. In this new edition, 75% of the "dilemmas" are brand new dilemmas facing the IBD specialist concerning emerging treatment therapies, such as the use of cannabinoids and Viagra for Crohn's disease. The remaining 25% of the dilemmas are fully updated from the previous edition, incorporating the latest clinical thinking 606 $aClinical dilemmas 606 $aInflammatory bowel diseases 606 $aInflammatory Bowel Diseases 606 $aInflammatory bowel diseases - Decision making 606 $aInflammatory bowel diseases -- Decision making 606 $aInflammatory bowel diseases$xDecision making 606 $aInflammatory bowel diseases 606 $aIntestinal Diseases 606 $aGastroenteritis 606 $aGastrointestinal Diseases 606 $aDigestive System Diseases 606 $aDiseases 606 $aInflammatory Bowel Diseases 606 $aMedicine$2HILCC 606 $aHealth & Biological Sciences$2HILCC 606 $aGastroenterology$2HILCC 615 4$aClinical dilemmas. 615 4$aInflammatory bowel diseases. 615 4$aInflammatory Bowel Diseases. 615 4$aInflammatory bowel diseases - Decision making. 615 4$aInflammatory bowel diseases -- Decision making. 615 0$aInflammatory bowel diseases$xDecision making 615 0$aInflammatory bowel diseases 615 2$aIntestinal Diseases 615 2$aGastroenteritis 615 2$aGastrointestinal Diseases 615 2$aDigestive System Diseases 615 2$aDiseases 615 2$aInflammatory Bowel Diseases 615 7$aMedicine 615 7$aHealth & Biological Sciences 615 7$aGastroenterology 676 $a616.344 700 $aIrving$b Peter$0956256 701 $aSiegel$b Corey A$0956257 701 $aRampton$b David$0457140 701 $aShanahan$b Fergus$0909421 801 0$bAU-PeEL 801 1$bAU-PeEL 801 2$bAU-PeEL 906 $aBOOK 912 $a9910139555703321 996 $aClinical Dilemmas in Inflammatory Bowel Disease$92165084 997 $aUNINA LEADER 00923nam 2200349 450 001 9910796702603321 005 20230807220509.0 010 $a2-335-08682-0 035 $a(CKB)3840000000374636 035 $a(MiAaPQ)EBC5044573 035 $a(Au-PeEL)EBL5044573 035 $a(OCoLC)1086130462 035 $a(EXLCZ)993840000000374636 100 $a20191119d2015 uy d 101 0 $afre 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aDon Pe?dre /$fVoltaire 210 1$a[Place of publication not identified] :$cLigaran,$d[2015] 210 4$dİ2015 215 $a1 online resource (78 pages) 676 $a862.3 700 $aVoltaire$f1694-1778,$0132570 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910796702603321 996 $aDon Pe?dre$93729726 997 $aUNINA LEADER 02478nam 2200589 450 001 9910812402903321 005 20170822144449.0 010 $a1-4704-0626-8 035 $a(CKB)3360000000465193 035 $a(EBL)3114272 035 $a(SSID)ssj0000889020 035 $a(PQKBManifestationID)11465752 035 $a(PQKBTitleCode)TC0000889020 035 $a(PQKBWorkID)10866256 035 $a(PQKB)10589055 035 $a(MiAaPQ)EBC3114272 035 $a(RPAM)16927855 035 $a(PPN)195418980 035 $a(EXLCZ)993360000000465193 100 $a20150416h20112011 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aJumping numbers of a simple complete ideal in a two-dimensional regular local ring /$fTarmo Ja?rvilehto 210 1$aProvidence, Rhode Island :$cAmerican Mathematical Society,$d2011. 210 4$dİ2011 215 $a1 online resource (78 p.) 225 1 $aMemoirs of the American Mathematical Society,$x0065-9266 ;$vNumber 1009 300 $a"November 2011, volume 214, number 1009 (end of volume)." 311 $a0-8218-4811-9 320 $aIncludes bibliographical references. 327 $a""Contents""; ""List of Figures""; ""Chapter 1. Introduction""; ""Chapter 2. Preliminaries on Complete Ideals""; ""Chapter 3. Arithmetic of the Point Basis""; ""Chapter 4. The Dual Graph""; ""Chapter 5. Multiplier Ideals and Jumping Numbers""; ""Chapter 6. Main Theorem""; ""Chapter 7. Proof of Main Theorem""; ""7.1. On Certain Intersection Products""; ""7.2. Key Lemmas""; ""7.3. Proof of Theorem 6.2""; ""Chapter 8. Jumping Numbers of a Simple Ideal""; ""Chapter 9. Jumping Numbers of an Analytically Irreducible Plane Curve""; ""Bibliography"" 410 0$aMemoirs of the American Mathematical Society ;$vNumber 1009. 606 $aIdeals (Algebra) 606 $aSingularities (Mathematics) 606 $aMultipliers (Mathematical analysis) 606 $aCurves, Plane 615 0$aIdeals (Algebra) 615 0$aSingularities (Mathematics) 615 0$aMultipliers (Mathematical analysis) 615 0$aCurves, Plane. 676 $a512/.44 700 $aJa?rvilehto$b Tarmo$f1965-$01699667 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910812402903321 996 $aJumping numbers of a simple complete ideal in a two-dimensional regular local ring$94082107 997 $aUNINA